Tzung-Han Chou

Prof. Tzung-Han Chou

Department of Chemical and Materials Engineering, National Yunlin University of Science and Technology, Yunlin 64002, Taiwan
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2010 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
Tzung-Han ChouTzung-Han Chou
Tzung-Han Chou
HDHsiou‐Yu Ding
Hsiou‐Yu Ding
WHWei Jing Hung
Wei Jing Hung
CLChia‐Hua Liang
Chia‐Hua Liang

1 July 2012 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
LCLeong-Perng Chan
Leong-Perng Chan
Tzung-Han ChouTzung-Han Chou
Tzung-Han Chou
HDHsiou-Yu Ding
Hsiou-Yu Ding
PCPin-Ru Chen
Pin-Ru Chen
FCFeng-Yu Chiang
Feng-Yu Chiang
CLChia-Hua Liang
Chia-Hua Liang

1 February 2000 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
Tzung-Han ChouTzung-Han Chou
Tzung-Han Chou
CCChien-Hsiang Chang
Chien-Hsiang Chang

30 April 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
WDWorku Batu Dirersa
Worku Batu Dirersa
TKTzu-Chun Kan
Tzu-Chun Kan
JCJungshan Chang
Jungshan Chang
Girum Getachew DemissieGirum Getachew Demissie
Girum Getachew Demissie
SOSonjid Ochirbat
Sonjid Ochirbat
JCJia-Yaw Chang
Jia-Yaw Chang
Of the most common, hypoxia, overexpressed glutathione (GSH), and insufficient H2O2 concentration in the tumor microenvironment (TME) are the main barriers to the advancment of reactive oxygen species (ROS) mediated Xdynamic therapies (X = photo, chemodynamic, chemo). Maximizing Fenton catalytic efficiency is crucial in chemodynamic therapy (CDT), yet endogenous H2O2 levels are not sufficient to attain better anticancer efficacy. Specifically, there is a need to amplify Fenton reactivity within tumors, leveraging the unique attributes of the TME. Herein, for the first time, we design RuxCu1-xO2-Ce6/CPT (RCpCCPT) anticancer nanoagent for TME-mediated synergistic therapy based on heterogeneous Ru-Cu peroxide nanodots (RuxCu1-xO2 NDs) and chlorine e6 (Ce6), loaded with ROS-responsive thioketal (TK) linked-camptothecin (CPT). The Ru-Cu peroxide NDs (RCp NDs, x = 0.50) possess the highest oxygen vacancy (OV) density, which grants them the potential to form massive Lewis's acid sites for peroxide adsorption, while the dispersibility and targetability of the NDs were improved via surface modification using hyaluronic acid (HA). In TME, RCpCCPT degrades, releasing H2O2, Ru2+/3+, and Cu+/2+ ions, which cooperatively facilitate hydroxyl radical (•OH) formation and deactivate antioxidant GSH enzymes through a cocatalytic loop, resulting in excellent tumor therapeutic efficacy. Furthermore, when combined with laser treatment, RCpCCPT produces singlet oxygen (1O2) for PDT, which induces cell apoptosis at tumor sites. Following ROS generation, the TK linkage is disrupted, releasing up to 92% of the CPT within 48 h. In vitro investigations showed that laser-treated RCpCCPT caused 81.5% cell death from PDT/CDT and chemotherapy (CT). RCpCCPT in cancer cells produces red-blue emission in images of cells taking them in, which allows for fluorescence image-guided Xdynamic treatment. The overall results show that RCp NDs and RCpCCPT are more biocompatible and have excellent Xdynamic therapeutic effectiveness in vitro and in vivo.

25 October 2010 in Journal of Natural Products
Verified
Journal Article
Closed access
Tzung-Han ChouTzung-Han Chou
Tzung-Han Chou
HDHsiou-Yu Ding
Hsiou-Yu Ding
RLRong-Jyh Lin
Rong-Jyh Lin
JLJing-Yao Liang
Jing-Yao Liang
CLChia-Hua Liang
Chia-Hua Liang

6 November 2019 in Journal of Materials Chemistry A
Verified
Journal Article
Closed access
PDF file
Li-Hsien YehLi-Hsien Yeh
Li-Hsien Yeh
ZHZih-Ying Huang
Zih-Ying Huang
YLYi-Cheng Liu
Yi-Cheng Liu
Ming-Jay DengMing-Jay Deng
Ming-Jay Deng
Tzung-Han ChouTzung-Han Chou
Tzung-Han Chou
Kevin C.-W.  WuKevin C.-W. Wu
Kevin C.-W. Wu
A polymer gel electrolyte-based nanofluidic osmotic power generator with substantially enhanced power performance is demonstrated.